CAMRF
CAMURUS AB by Camurus AB (CAMRF)
$51
About CAMURUS AB by Camurus AB (CAMRF)
Camurus AB is a research based pharmaceutical company, which engages in the research, development, and commercialization of specialty medicines. It provides its products for the treatment of severe and chronic conditions, which includes opioid dependence, pain, cancer and endocrine disorders. The company was founded by Marcus Kare Torleif Larsson in 1991 and is headquartered in Lund, Sweden.
Details
Daily high
--
Daily low
--
Price at open
--
52 Week High
$71.00
52 Week Low
$54.00
Market cap
3.5B
Dividend yield
0.00%
Volume
--
Avg. volume
9
P/E ratio
48.15
CAMURUS AB by Camurus AB News
Details
Daily high
--
Daily low
--
Price at open
--
52 Week High
$71.00
52 Week Low
$54.00
Market cap
3.5B
Dividend yield
0.00%
Volume
--
Avg. volume
9
P/E ratio
48.15